ASBM Chairman Dr. Richard Dolinar convened a working group of Advisory Board members to discuss the elements of a physician notification policy for biosimilars that prioritizes patient safety. Read the summary.
Media Room
ASBM Advisory Board Members Convene on Physician Notification
Monday, June 18th, 2012